SINEMET Supply Shortage Update – February 2021

We have received the following update to the supply of SINEMET CR® (levodopa/carbidopa) 200 mg/50 mg controlled release tablets.

The long-standing shortage of a formulation of Levodopa/Carbidopa 200/50 (Sinemet CR) has been resolved.

The manufacturers, MSD (Merck, Sharp & Dohme) Australia, have announced that this medication is once again available. The only change is that Sinemet CR will now be packed in a bottle containing 100 tablets as opposed to the previous packaging in a blister pack containing 60 tablets.

Naturally any queries about prescribing of this medication should be directed to your treating medical specialist.

See attached PDF.

20210211-Sinemet CR
Download PDF • 286KB

For more background see earlier news item.